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Abstract 
Substitution of Leu-40 by Pro in the j3 subunit @L4OP) of Escherichia coli F,-ATPase caused a decrease in the amount of the a and /I subunits 
on the membranes. A revertant strain, Re50, carrying no suppression mutations in the uncD gene encoding the/? subunit, was isolated from the/?L40P 
mutant. The uncA gene from this revertant was amplified by PCR, and cloned into an expression plasmid. The expression plasmid carrying the uncA 
gene from the revertant was used for genetic suppression assays. The suppression mutation in Re50 was in the a subunit, and it recovered the assembly 
of the a and /I subunits into the F,F, complex and the ATPase activity to 50% that of the wild type. In Re50, Leu-I 11 was substituted by Gln in 
the u subunit. These results suggest that the regions including Leu-40 in the /I subunit and Leu-1 11 in the a subunit are located close together and 
interact with each other, either directly or indirectly. 
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1. Introduction the molecular mechanisms of this enzyme, has not yet 
been elucidated. 
The proton translocating ATPase F,F, of Escherichiu 
coli catalyzes the synthesis and hydrolysis of ATP as the 
key enzyme of biological energy transduction [1,2]. This 
enzyme consists of peripheral and integral membrane 
parts. The peripheral part, F,, has five non-identical sub- 
units, 01, p, y, 6, and E and has the catalytic activity. The 
integral part, F,, has proton channel function. The puri- 
fied CZ, /I, and y subunits reconstitute the ATPase activity 
[3]. The primary structures of all subunits have been 
determined, and essential and important residues of the 
subunits for the catalytic function and molecular assem- 
bly have been investigated [4,5]. However, the topologi- 
cal arrangement of the subunits within the enzyme com- 
plex, which arrangement is important for understanding 
The /I subunit has nucleotide binding activity and is 
believed to contain the catalytic center [ 1,2]. Although it 
is known that the central portion of the subunit between 
residues 140 to 340 provides the binding site for nucleo- 
tide [5], the function of other portions, such as the amino 
and carboxyl terminal regions, has not been established. 
We have shown that a pL4OP mutation caused defective 
molecular assembly of the 01 and /I subunits on the mem- 
brane, suggesting that the region around the residues is 
important for the integration of the a and/3 subunits into 
the F,F, complex [6]. Here we provide evidence that a 
second-site mutation at Leu-111 in the a subunit could 
suppress the defective molecular assembly caused by the 
original mutation of pL4OP, suggesting that both regions 
including, olLll1 or jIL40, are important for the interac- 
tion between the 01 and /? subunits. 
*Corresponding author. 
**Present address: Tsukuba Institute, Yamanouchi Pharmaceutical 
Co., Japan. 2. Materials and methods 
Abbreviations: F,F,, proton translocating ATPase for oxidative phos- 
phorylation, PCR, polymerase chain reaction; bp, base pair(s). Codons 
are numbered starting from the second codon of the gene coding for 
the /I subunit, as amino terminal methionine is missing in the isolated 
B subunit [18]. Residues and mutations are referred to as follows: 
bGl49 represents normal F, /I subunit residue Gly-149. /?Gl49S repre- 
sents a substitution of Ser at residue 149 of the/J subunit instead of Gly. 
The residue numbers used in this paper refer to the E. coli enzyme. 
2.1. Bacterial strains and growth conditions 
An E. coli mutant strain, JP17 (AuncD, argH, pyrE, entA, 
recA:: TnlO), carrying the deletion mutation of the uncD gene encoding 
the /J subunit [7], donated by A.E. Senior, University of Rochester 
School of Medicine and Dentistry, was used. Minimal medium [8] 
containing required supplements plus a carbon source (0.5% succinate 
or 0.2% glucose), and rich medium (L-broth) [8] were used for genetic 
assays and biochemical analyses. For membrane preparation, cells were 
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grown in minimal medium with 0.5% glycerol. Transformants by plas- 
mids were selected by resistance to ampicillin (50 &ml) or chloram- 
phenicol (50 &ml). 
2.2. Expression plasmids for the a and B subunits 
In this study, we constructed the a subunit expression plasmid 
pRM17 (Fig. IA), using pBR322 [9] as a vector The restriction sites 
of EcoRI, ClaI, and Hind111 on pBR322 were modified by digestion 
with the appropriate restriction enzymes and by subsequent endfilling, 
using the Klenow fragment of DNA polymerase I. This plasmid carries 
DNA fragments containing the promoter region of the unc operon and 
uncA gene encoding the entire a subunit as HaeII-Hind111 and 
HindIIIIBamHI fragments, respectively. The HindIII-BamHI frag- 
ment carrying the uncA gene was prepared as follows: the entire coding 
region of the a subunit was amplified with PCR [20] and digested with 
EcoRV and BamHI. These sites were then introduced into the 5’- and 
3’- end of the a subunit gene by PCR with the respective synthetic 
primers. The synthetic primers, AEF-Nl 0 (5’-TACTGA- 
TATCTAGACGTCTTGCAGTCTT-3’) and AER-C2 (5’-GCCTG- 
GATCCTCAATGCCTTGCGG-3’) are carrying the recognition se- 
quences of EcoRV and BamHI flanked by the 5’- ends of the primers, 
respectively. The EcoRV-BamHI fragment carrying the entire uncA 
gene was introduced between the HincII and BumHI sites of pUCl9 
[IO]. The HindIIIIBamHI fragment carrying the uncA gene was recov- 
ered from this recombinant plasmid. 
The B subunit expression plasmid pRM25 (Fig. 1B) was constructed 
using nACYCl84 1111 as a vector. This nlasmid carries DNA fragments __ . 1 
containing the same promoter region as the pRMl7 and uncD gene 
encoding the entire/I subunit in the HaeIIIBamHI region. The HindIIII 
BumHI fragment carrying the entire uncD gene was recovered from 
another recombinant plasmid pST03B [6], and introduced into this 
plasmid. The HindIII-BamHI fragment carrying the BL4OP mutation, 
recovered from a plasmid, 31-134, which had been isolated previously 
161, was introduced into the pRM25. The resulting plasmid was named 
pRM25-j3L40P. The ClaIIHaeII fragment in this p&mid was obtained 
from the modified ~BR322 in which the EcoRI and Hind111 sites were 
modified by digestion and subsequent endfilling, as described above. 
Treatment with restriction endonucleases and DNA ligase, and the 
isolation and cloning of the DNA fragments into vectors were per- 
formed as described previously [12]. 
2.3. Isolation of the revertants and suppression assay of cloned uncA 
gene 
Spontaneous revertants were selected as colonies capable of growth 
on the minimal medium agar supplemented with succinate from JP17 
carrying the pST03j3-L40P, which is the expression plasmid of the B 
subunit with theBL40P mutation [6]. The plasmids were recovered from 
these revertants, and introduced again into JP17 to test whether the 
plasmids carried reversion mutations. Total DNA, which was prepared 
by procedures already described [19] from the revertant that did not 
carry the reversion mutations on the plasmid, was used for the PCR 
template. The DNA fragments encoding the a subunit were amplified 
by PCR with oligonucleotides AEF-NlO and AER-C2. The amplified 
DNA was digested with EcoRI and BamHI (Fig. 1A). The fragments 
were ligated with pRM 17 digested with EcoRI and BarnHI, and resul- 
tant plasmids were introduced into the JP17 carrying pRM25-BL40P. 
We tested whether the transformants could grow on succinate to assess 
the suppression activity of the cloned uncA gene. 
2.4. Sequencing 
The nucleotide sequences in which suppression mutations were 
mapped (XhoIIClaI) (Fig. 1A) were determined using the isolated plas- 
mids as the template for the dideoxinucleotide chain-termination reac- 
tion [I 31. [a-35S]dCTP (37 TBq/pmol) was used for labeling. 
2.5. Other methods 
Cells harvested in the late logarithmic phase of growth were passed 
through a French Pressure Cell and the membranes were isolated as 
described previously [S]. The ATPase activity and protein concentra- 
tion were assayed, using reported procedures [14,15]. The a and B 
subunits on the membranes were detected immunologically by Western 
blotting analysis, as described previously [16]. 
2.6. Reagents and chemicals 
We purchased the restriction endonucleases, the Klenow fragment of 
DNA polymerase I, and T4 DNA ligase from Life Technologies, Inc., 
and Z’th DNA polymerase from Toyobo Co., Tokyo, Japan. [a- 
“S]dCTP was purchased from DuPont/NEN Research Products. Other 
materials were of the highest grade commercially available. 
3. Results 
3.1. Isolation of the intergenic suppression mutants from 
the ,8LlOP mutant and mapping the mutations 
Revertants were isolated as clones, capable of growing 
on the agar containing succinate as the sole carbon 
source, from a defective mutant with the jIL4OP substitu- 
tion. As the parent mutant cells, we used transformants 
of the /J-less mutant JP17 with a plasmid, pST03/I-L40P, 
that expressed the defective /? subunit gene with the 
/?L4OP mutation. One hundred and twenty six independ- 
ent clones were isolated as the revertants from 1.2 x 10” 
cells of the transformants. The plasmids isolated from 13 
revertants were introduced again into JP17. The comple- 
mentation test showed that a plasmid derived from rever- 
tant strain, RE50, did not exhibit the revertant pheno- 
type, while the other plasmids did. These results sug- 
gested that the suppression mutations occurred in genes 
other than the j? subunit gene in RE50. Reversion muta- 
tions in the other revertants were found in the /? subunit 
gene, and their altered nucleotide sequences were re- 
ported previously [6]. 
Fig. 1. Expression plasmids of the uncA and uncD gene, encoding E. 
coli a and B subunits, respectively. (A) The 470-bp (HaeIIIIHindIII) 
fragment carrying the promoter region (uncP) of the unc operon and 
the 1,638bp (HindIII-BamHI) fragment carrying the uncA gene were 
cloned into modified pBR322 as described in section 2. (B) The same 
promoter region of pRMl7 and the HindIII-BamHI fragment (1,785- 
bp) carrying the uncD gene were cloned into pACYC184 as described 
in section 2. The Cl&Hue11 region was obtained from the modified 
pBR322, in which the EcoRI and Hind111 sites were modified. Restric- 
tion sites are abbreviated as follows: H2, HaeII; H3, HindIII; E, EcoRI; 
B, BarnHI; C, ClaI; X, XhoI. Regions including the ampicillin-resistant 
gene (Amp) and chloramphenicol-resistant gene (Cm) are shown. 
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Fig. 2. Mapping and DNA sequencing of the suppression mutation in 
the uncA gene from RE50. DNA segments carried by recombinant 
plasmids are shown with a base substitution in the revertant strain 
RE50 identified from the DNA sequence. (A) Recognition sites of 
restriction enzymes used in this study. Nucleotides are numbered start- 
ing from the Hind111 site. (B) The DNA fragments carried by recombi- 
nant plasmids used for the mapping of the suppression mutation. (C) 
Base substitution and amino acid replacement in RE50 determined 
from the DNA sequence. 
3.2. Fine mapping and determination of the altered 
sequence 
We speculated that the suppression mutation may 
have occurred in the a subunit. To test this possibility, 
we cloned the a subunit gene from the revertant and 
tested the suppression activity of the gene in the parent 
mutant with the defective /_? subunit. The DNA fragment 
encoding the a. subunit was amplified using the PCR, and 
the EcoRI-BamHI fragment was substituted for the cor- 
responding region in the pRM17 (Fig. lA), which is the 
expression plasmid for the a subunit gene. The DNA 
fragment from the revertant DNA lacked the sequence 
coding the first 3 residues of the a subunit from the 
amino terminal. The constructed plasmid was then intro- 
duced to JP17 carrying the pRM25-/3L40P. The plasmid 
derived from RE50 suppressed phenotype of the JP17 
carrying pRM25-/3L40P, which did not grow on the suc- 
cinate plate, indicating that the suppression mutations 
were in the a subunit gene. The pRM 17 carrying the wild 
type a subunit gene did not show the suppression activ- 
ity. The DNA encoding the a subunit of RE50 in the 
plasmid was divided into two portions, between the 
Hind111 and CZaI sites (594 bp) and between theCla1 and 
BamHI sites (1,044 bp) (Fig. 1 A), and each fragment was 
introduced into pRMl7. Suppression activity in the JP17 
carrying pRM25-j?L40P was observed within the DNA 
fragment between HindIII-CZaI encoding the amino ter- 
minal 179 residues. Within this region, the suppression 
activity was located in the DNA fragment between XhoI 
and ClaI(343 bp), using the same procedures described 
above. The entire sequence of this fragment derived from 
RE50 was determined. For RE50, substitution of single 
base thymine by adenine was observed at the Leu-111 
codon, causing a change from Leu to Gln (Fig. 2). 
3.3. Characterization oj’ the revertants 
The parent mutant with the j?L4OP mutation exhibited 
4% of the wild type F,F, ATPase activity on the mem- 
branes and decreased amounts of the a and J3 subunits 
on the membranes [6]. RE 50 had 42% of the wild type 
activity (Table 1) and recovered the a. and j? subunits on 
the membranes to the wild type level (Fig. 3). Thus, it 
was concluded that the assembly defect caused by the 
j?L4OP mutation could be recovered extensively by the 
substitution of Leu-111 by Gln in the a subunits. 
4. Discussion 
We have previously shown that /3L40 and /3E41 are 
involved in the epitope residues for the monoclonal anti- 
body 831 [6]. The binding of these antibodies to the p 
subunit was lost after assembly of the F,-ATPase com- 
plex, suggesting that the region around residues 40 and 
41 is exposed to the surface of the B subunit and con- 
cealed in the F,-ATPase complex [16]. Mutations of p 
L4OP and BE41 K caused a defect in the molecular assem- 
bly of the a and J3 subunits on the membranes. Although 
these residues are located side by side, we found that the 
phenotypes of the defective assembly of the a and B 
subunits were different. The j.IL4OP mutation caused a 
decrease in both the a and /I subunits, while the E41K 
mutation decreased the a subunit only, with a normal 
amount of thep subunit. It has been demonstrated that 
the wild type /3 subunit binds to the membranes without 
the a subunit [22]. We observed that the a subunit did 
not bind to the membranes without the /3 subunit in a 
p-less mutant, JP17 [6]. These findings suggested that 
integration of the a andp subunits into the F,F, complex 
requires two steps: (i) the binding of the/J subunit to the 
F, portion, possibly with some F, subunits such as the 
6 subunit, and (ii) the subsequent binding of the a sub- 
unit to the /J subunit. The j?L4OP mutation seems to 
affect mainly the binding of the j? subunit to the F, 
portion, and the E4 1 K mutation alters the binding of the 
B subunit to the a subunit. We have no direct evidence 
to show whether or not the /3L4OP mutation affects the 
Table 1 
ATPase activity on the membranes of RE50, isolated from the BL4OP 
mutant 
Plasmid ATPase activity (units/mg) 
pST038 (Wild) 
pST03/?-L40P 
pRE50 
4.3 (100) 
0.2 (4) 
1.8 (42) 
Membrane vesicles were prepared as described previously [20]. ATPase 
activity was assayed in the presence of Mg’+ ions, as previously reported 
[27]. Figured in parentheses indicate relative activity. 
190 
1 2 3 
a, 
P” 
Fig. 3. Western blot analysis the a on the membranes 
a subunit carrying 
in the cytoplasmic by 12.5% SDS-poly- 
acrylamide gel electrophoresis. 
a and j? subunits were 
probed in 
preparation), respectively. 
a region different from by /?12 83 I, Lanes: 1, JP17 
carrying pST03j? (wild type); 2, JPl7 carrying pST03/?-L40P; 3, RE50. 
binding of the/3 subunit to the CI subunit. However, since 
these two residues are located side by side, it is conceiv- 
able that the pL4OP may cause some alteration in this 
binding. 
In this study, we have shown that the second site mu- 
tation at Leu-1 11 in the 01 subunit suppressed the defect 
of the j? subunit carrying the jIL4OP mutation. This find- 
ing suggested that BL4OP affected the interaction be- 
tween the /I and CI subunits. Therefore, it is possible that 
/IL40 may be involved in the a-/3 interaction, either di- 
rectly or indirectly. It is difficult to assess the contribu- 
tion of j?L4OP in the interaction of the j? subunit to the 
F, portion and to the a: subunit. The CI subunit carrying 
the clLll1Q mutation may bind to the /I subunit, leading to 
the restoration of an essential conformation in the binding 
of the p subunit with the pL4OP mutation to the F,. The 
aLl11Q mutation itself, or the region containing this 
suppression mutation, could be involved in the binding 
domain of the cz subunit to the /I subunit. It should be 
noted that the regions containing pL40 and pE41, and 
aL111 have similar sequences to those from Bacillus 
strain PS3 and that those regions of PS3 are looped out 
to the surface of the /I and 01 subunits, respectively 
[23,24]. 
The membrane vesicles from JP17 carrying pRM25- 
j?L4OP had 20% of the wild type a and p subunits, and 
the revertant carrying the aL1llQ mutation in its chro- 
mosomal DNA had the same amounts of these subunits 
as the wild type. However, they had only 4% and 42% 
of the wild-type ATPase activity, respectively, lower than 
would be expected from the amounts of a and /I subunits 
on the membranes. These results suggest that an interac- 
tion between the 01 and /3 subunits altered by the j?L4OP 
mutation caused the defect in the catalytic mechanisms; 
this finding also supports the notion that /IL40 is in- 
volved in the cl_18 interaction. 
The region between residues 345 and 375 in the a 
subunit may be involved in the signal transmission be- 
tween the a and /I subunits required for steady-state 
catalysis [5]. As shown by the three-dimensional arrange- 
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ment of the 0: and p subunits in the F,-ATPase complex 
obtained on X-ray crystallographic analysis [17], these 
subunits have three pairs in one complex and they oc- 
cupy the alternating positions. Therefore, there are at 
least two different sites in each /I subunit that interact 
with the next CI subunit. The clLll1 may be involved in 
one of these interacting sites, with or without the region 
between residues 345 and 375. 
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